Aortyx
Aortyx has developed a biomimetic bioresorbable adhesive patch to treat aortic dissections. It helps to stop false lumen blood flow, promotes natural repair and bio integration.
- horizon europe
- woman founder
- spinout
- eit ecosystem
- surgery
- cardiology and cardiovascular
- eit health
- eit supernovas
- eicfund
- headstart (eit health)
- tissue engineering
- european health catapult (eit health)
- regenerative medicine
- headstart 2019 (eit health)
- european health catapult 2020 (eit health)
- caixa impulse (eit health)
- caixa impulse 2017 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €13.8m | Series A | |
| Total Funding | 000k | ||
| EUR | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (93 %) | 1830 % |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | (25 %) | (7 %) | (535 %) |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (49 %) | (877 %) | (436 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Developer of endovascular devices intended to treat vascular diseases. The company's devices focus on tissue regeneration by mimicking the aorta biomechanical environment and provide a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta, enabling professionals to treat vascular diseases in an efficient manner.
Keywords: Healthcare Devices, Services, Supplies, Aortic Disease Treatment, Biomechanical Environment, Cell Migration, Cell Proliferation, Endovascular Device, Vascular Disease.